OpenSecrets.org @OpenSecretsDC
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the administration in the first quarter of 2020 than it ever has before. https://t.co/PxiMfICLSw — PolitiTweet.org